Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
暂无分享,去创建一个
Harvey Risch | Malcolm C Pike | Georgia Chenevix-Trench | Argyrios Ziogas | Jolanta Lissowska | Stefan Nickels | Hoda Anton-Culver | Jenny Chang-Claude | Daniel O Stram | Ellen L Goode | Brooke L Fridley | Montserrat Garcia-Closas | Nicolas Wentzensen | Susanne K Kjaer | Weiva Sieh | Rachel Palmieri Weber | Usha Menon | Aleksandra Gentry-Maharaj | Valerie McGuire | Rebecca Hein | Joellen M Schildkraut | Celeste Leigh Pearce | A. Whittemore | L. Kiemeney | M. Pike | R. Vierkant | J. Chang-Claude | M. García-Closas | B. Fridley | E. Goode | A. Berchuck | E. Iversen | P. Pharoah | D. Stram | A. Ziogas | H. Anton-Culver | U. Menon | A. Gentry-Maharaj | K. Aben | G. Chenevix-Trench | L. Brinton | J. Lissowska | J. Cunningham | M. Goodman | S. Kjaer | R. Hein | S. Nickels | A. Wu | S. Gayther | N. Wentzensen | R. Ness | H. Risch | R. Weber | J. Doherty | J. Schildkraut | K. Moysich | P. Moorman | L. Massuger | A. V. van Altena | C. Pearce | M. Carney | V. McGuire | W. Sieh | M. Rossing | P. Webb | A. Jensen | G. Lurie | E. Høgdall | S. Ramus | P. Thompson | Alice W. Lee | K. Terry | D. Stram | Andrew Berchuck | Leon F A G Massuger | Marc T Goodman | Paul Pharoah | Julie M Cunningham | Penelope M Webb | Susan J Ramus | Estrid Hogdall | Simon A Gayther | Anna H Wu | Jennifer A Doherty | Mary Anne Rossing | Galina Lurie | Patricia G Moorman | Louise Brinton | Robert A Vierkant | Michael E Carney | Pamela J Thompson | Kathryn L Terry | Allan Jensen | Lambertus A L M Kiemeney | Roberta B Ness | Katja K H Aben | Kirsten Moysich | Edwin Iversen | Alice W Lee | Susan M Jordan | Douglas A Stram | Anne M Van Altena | Alice Whittemore | S. M. Jordan | Daniel O. Stram | Douglas A. Stram | R. P. Weber | A. van Altena | A. Wu
[1] R. Sankila,et al. Cancer incidence in the first-degree relatives of ovarian cancer patients. , 1996, British Journal of Cancer.
[2] Mark Sherman,et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. , 2009, Cancer research.
[3] L. Sobin,et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. , 2003, American journal of epidemiology.
[4] A. Whittemore,et al. Histologic types of epithelial ovarian cancer: have they different risk factors? , 2005, Gynecologic oncology.
[5] References , 1971 .
[6] F. Nezhat,et al. Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial , 2011 .
[7] A. Whittemore,et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.
[8] D. Seminara,et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] David N. Rider,et al. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis , 2009, British Journal of Cancer.
[10] R. Ness,et al. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. , 2011, Annals of epidemiology.
[11] T. Stijnen,et al. Review: a gentle introduction to imputation of missing values. , 2006, Journal of clinical epidemiology.
[12] B. Thomsen,et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. , 2004, Archives of internal medicine.
[13] M. Pike,et al. Markers of inflammation and risk of ovarian cancer in Los Angeles County , 2009, International journal of cancer.
[14] P. Hartge,et al. Ovarian cancer risk factors by histologic subtypes in the NIH‐AARP diet and health study , 2012, International journal of cancer.
[15] David V Conti,et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. , 2011, Human molecular genetics.
[16] N. Weiss,et al. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery , 2008, Cancer Causes & Control.
[17] A. Whittemore,et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.
[18] A. Whittemore,et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. , 2004, American journal of epidemiology.
[19] A. Berchuck,et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. , 2008, American journal of epidemiology.
[20] C. la Vecchia,et al. Risk factors for different histological types of ovarian cancer , 2003, International Journal of Gynecologic Cancer.
[21] A. Green,et al. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer , 2008, International journal of cancer.
[22] H. Risch,et al. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. , 1996, American journal of epidemiology.
[23] D. Easton,et al. Risk prediction models for familial breast cancer. , 2006, Future oncology.
[24] P. Dickman,et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.
[25] M. Widschwendter,et al. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.
[26] L. Wilkens,et al. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk , 2010, Cancer Causes & Control.
[27] V. Beral,et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls , 2008, The Lancet.
[28] P. Hartge,et al. Multiple births and risk of epithelial ovarian cancer. , 2000, Journal of the National Cancer Institute.
[29] M. Pike,et al. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. , 2004, Fertility and sterility.
[30] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.
[31] J. Chang-Claude,et al. Low‐dose oral contraceptives: Protective effect on ovarian cancer risk , 2001, International journal of cancer.
[32] A. Whittemore,et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.
[33] M. Pike,et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies , 2012, The Lancet. Oncology.
[34] J. Gohagan,et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.
[35] Matthew Burnell,et al. Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study. , 2011, Journal of clinical epidemiology.
[36] C. la Vecchia,et al. Risk factors for ovarian cancer histotypes. , 2007, European journal of cancer.